Takeaways From the Big Long COVID Clinical Trials

Takeaways From the Big Long COVID Clinical Trials

by | Apr 21, 2026 | Amytriptyline, Antivirals, CoQ10, COVID-19, Homepage, Inflammation, Ivabradine, Klimas, Lipids, long COVID, Mast cell activation syndrome, Microbiome, Orthostatic intolerance, Paxlovid, POTS, Treatment

Only 10 major long COVID clinical trials have been published thus far but that's enough to come away with some interesting takeaways. They include treatments that prevent long COVID don't necessarily treat it, broader based treatments are probably best, manipulating the gut can help with fatigue (but only so much), and an as yet unassessed class of drugs may be helpful.
Blood, Sex and Inflammation: Did the IMPACC Study Uncover Core Issues in Long COVID and ME/CFS?

Blood, Sex and Inflammation: Did the IMPACC Study Uncover Core Issues in Long COVID and ME/CFS?

by | Mar 5, 2026 | Baricitinib, Cardiovascular, Clotting, Complement, COVID-19, Endothelial Cells, Energy Production, Homepage, Hypoxia, Inflammation, Klimas, long COVID, Metabolism, Muscles, Oxidative Stress, Proteomics

The big IMPACC long COVID study findings suggest that inflammation and reduced male sex hormone levels may be playing havoc with the small blood vessels in long COVID -= and ME/CFS
The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

by | Nov 3, 2025 | COVID-19, Dempsey, Epstein-Barr Virus, GLP-1, Gut, Homepage, Immune, Inflammation, Kaufman, Mast cell activation syndrome, Mast cell activation syndrome, Neuroinflammation, Pathogens, POTS, RECOVER Initiative, Severe ME/CFS, Treatment

Complex, chronic illness experts discuss what GLP-1 agonists can and can't do in diseases like ME/CFS, long COVID, and POTS. Plus new long COVID trials.
PrecisionLife’s Bold Attempt to Break the Code on and Beat ME/CFS and Long COVID

PrecisionLife’s Bold Attempt to Break the Code on and Beat ME/CFS and Long COVID

by | Oct 27, 2025 | Artificial Intelligence, COVID-19, Energy Production, Genetics, GWAS (Genome-Wide Association Study), Homepage, Low Dose Naltrexone, Metabolism, Monocytes, Oxidative Stress, Pathogens, Research, T-cells

Geoff’s Narration The GIST   This is the next in a series of blogs exploring ongoing projects in ME/CFS, FM and long COVID. The first featured the RECOVER project’s next set of long COVID clinical trials.  RECOVER’s 2nd Round of Long COVID...
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest